Skip to main content

Table 1 Diseases identified in people admitted to skilled nursing homes by sex and age

From: Impact of nursing home admission on health care use and disease status elderly dependent people one year before and one year after skilled nursing home admission based on 2012–2013 SNIIRAM data

 

Women

Men

Total

Age (years)

65–74

 

75–84

 

≥ 85

 

65–74

 

75–84

 

≥ 85

   

N

404

2450

6015

340

936

1542

11,687

 

2012

2013

2012

2013

2012

2013

2012

2013

2012

2013

2012

2013

2012

2013

Parameters

%

%

%

%

%

%

%

%

%

%

%

%

%

%

Cardiovascular and neurovascular disease

32.2

32.9

35.7

41.4***

44.0

52.1***

45.0

47.6

56.6

59.9

56.7

65.0***

44.6

51.4***

 Acute

11.4

6.4*

7.1

7.1

7.9

10.6***

14.7

5.6***

9.6

6.9*

8.9

9.8

8.4

9.2*

 Chronic

27.5

30.4

33.5

39.0***

42.1

49.9***

38.5

45.9

53.7

58.7*

54.7

63.3***

42.3

49.3***

Coronary heart disease

9.4

8.7

10.0

11.5

12.6

14.5**

15.6

16.2

22.9

22.9

22.0

23.6

14.1

15.6**

 Acute coronary syndrome

NA

NA

0.6

0.6

0.6

0.6

NA

NA

NA

NA

0.9

0.6

0.6

0.6

 Chronic coronary heart disease

8.9

8.2

9.4

10.9

12.0

13.9**

14.4

15.6

22.5

22.4

21.1

23.0

13.5

15.0***

Stroke

17.3

19.1

12.5

14.8*

10.1

13.1***

23.5

22.6

17.8

19.0

13.4

16.6*

12.3

14.8***

 Acute stroke

8.2

4.0*

4.0

2.8*

3.2

3.1

10.9

NA

5.4

2.2***

3.5

2.5

4.0

2.9***

 Stroke sequelae

9.2

15.1*

8.5

12.0***

6.8

10.0***

12.6

20.3**

12.4

16.8**

9.9

14.1

8.3

12.0***

Heart failure

6.2

6.2

8.7

10.3

13.3

18.9***

10.0

12.4

12.8

16.0*

14.7

20.9***

12.1

16.5**

 Acute

3.2

NA

2.4

3.1

3.9

6.6***

3.8

NA

3.2

4.2

4.3

6.2***

3.5

5.3***

 Chronic

3.0

4.7

6.3

7.2

9.4

12.3***

6.2

10.0

9.6

11.9

10.4

14.8*

8.6

11.2***

Peripheral arterial occlusive disease

3.7

3.7

4.7

4.9

5.1

5.8

7.9

7.9

10.3

10.0

9.0

9.9***

6.0

6.5

Arrhythmias or conduction disorders

10.4

9.9

15.8

18.9**

21.6

25.9***

11.8

11.2

23.6

25.7

27.7

33.7***

20.7

24.5***

Valvular heart disease

3.7

NA

3.8

3.6

5.4

5.7

NA

NA

4.1

4.5

4.7

5.5

4.7

4.9

Diabetes

17.8

20.0

18.4

18.9

13.3

13.9

20.6

23.2

23.9

24.9

17.4

17.8

16.2

16.8

 Insulin-treated

5.9

8.4

6.0

6.7

4.2

5.1*

5.9

10.0*

7.3

9.0

5.1

6.3

5.0

6.2***

 Non-insulin-treated

11.9

11.6

12.5

12.3

9.2

8.8

14.7

13.2

16.7

15.9

12.3

11.5

11.1

10.7

Cancer

10.6

11.9

13.6

14.0

13.0

13.7

12.6

14.1

23.0

25.4

25.2

26.7

15.4

16.4*

 Active

4.5

4.7

4.0

4.3

4.0

4.4

5.0

5.0

8.5

10.8

11.3

12.3

5.4

6.0*

 Under surveillance

6.7

7.7

10.1

10.1

9.2

9.6

8.5

9.1

15.3

16.1

15.0

15.6

10.5

10.9

Breast

3.7

4.2

6.4

6.4

4.5

4.5

3.8

3.8

Colon

NA

NA

1.6

1.6

2.2

2.5

NA

NA

3.4

3.7

3.1

3.2

2.3

2.5

Prostate

3.8

3.2

10.1

11.3

11.2

11.6

2.4

2.5

Psychiatric disorders

39.6

43.1

21.7

23.7

9.0

11.6***

37.1

41.5

18.3

22.8*

7.5

10.6**

14.1

16.8***

Psychotic disorders

13.1

14.1

3.8

4.1

1.1

1.3

13.2

12.9

2.2

2.7

NA

0.7

2.4

2.7

Neurotic and mood disorders

21.5

24.3

13.3

14.4

5.2

6.9***

10.9

13.8

8.8

10.1

3.9

5.0

7.7

9.3***

 Bipolar and manic disorders

5.7

6.7

2.4

2.7

0.6

0.6

NA

3.8

1.4

1.5

NA

NA

1.2

1.4

 Depression, other mood disorders

13.1

14.4

8.2

9.0

3.1

4.4***

5.9

7.1

4.8

5.9

2.5

3.4

4.6

5.8***

 Neurotic disorders

6.2

7.9

4.8

4.9

2.0

2.5

3.8

3.5

3.8

4.1

1.4

1.6

2.8

3.2

Substance abuse disorders

5.9

5.0

1.1

1.1

0.1

0.1

8.2

8.8

1.6

1.6

NA

NA

0.9

0.9

Neurological or degenerative diseases

46.5

52.7

51.9

64.2***

35.4

48.1***

37.6

45.0

52.2

62.0***

33.6

48.9***

40.4

52.8***

Degenerative diseases

38.9

44.8

49.9

62.2***

34.6

47.0***

26.5

33.8*

50.3

60.0***

32.2

47.3***

38.6

50.8***

 Dementia

34.9

41.1

44.3

56.6***

32.4

44.5**

22.1

28.5

42.3

52.0***

27.6

42.9***

34.8

46.9***

 Parkinson’s disease

7.9

8.9

8.2

9.5

3.4

4.1

9.1

10.9

14.9

17.2

6.6

7.7

6.1

7.1**

Neurological diseases

10.6

12.4

3.3

4.3

1.7

2.5**

13.8

15.3

4.4

4.8

2.3

3.0

3.0

3.8**

 Epilepsy

4.7

6.4

1.6

2.5*

0.9

1.6***

8.8

9.7

2.8

3.2

1.5

2.0

1.7

2.4***

Chronic respiratory diseases

10.1

9.2

10.1

10.5

10.3

12.3

16.2

16.2

14.5

16.0

13.8

16.7*

11.2

12.8***

Inflammatory or rare diseases or HIV or AIDS

4.0

3.5

4.7

4.7

3.2

3.5

NA

2.9

3.0

2.7

2.3

3.0

3.4

3.6

Chronic inflammatory diseases

3.2

2.7

4.2

4.3

2.9

3.1

NA

NA

2.4

2.1

1.9

2.4

2.9

3.1

 Rheumatoid arthritis

NA

NA

2.2

2.2

1.7

1.7

NA

NA

NA

NA

1.0

1.1

1.5

1.6

Diseases of the liver or of pancreas

3.7

2.5

1.9

2.0

1.4

1.4

4.4

3.5

2.7

3.5

1.4

1.6

1.8

1.8

Other chronic diseases

11.4

13.6

10.1

11.6

12.4

14.8***

9.1

11.5

7.5

8.2

7.3

9.4*

10.7

12.8***

  1. NA data not available for sample sizes <10
  2. Comparison before and after admission ***p < 0.001, ** < 0.01,* p < 0.05
  3. For parameters definition, see Additionnal file 1